Drug Discovery

Bone cancer
#Bone cancer #Cancer therapy #Chordoma #DNA #Drug discovery #Rare disease

New therapy to treat rare bone cancer chordoma

A paper published in Nature Communications by a team of researchers from Oxford and North Carolina provides structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapy. Unpacking brachyury According to the paper’s abstract1, Brachyury is a transcription factor that affects tumour growth of the… Read More

#News

#Drug discovery

Webinar: Advance Your MASH Research with the Right Rodent Models

Discover how to optimise your MASH (formerly NASH) preclinical studies with a mouse model generation expert. Watch this Taconic Biosciences webinar to:  Learn best practices for model selection, cohort design, and translational relevance.  Explore a real-world case study on successful model application in MASH drug development.  Gain key strategies to… Read More

#Webinars

#Collaboration #Drug discovery #Mergers and acquisitions #Partnership

The new industry deals progressing drug discovery

New partnerships, acquisitions and collaborations are helping drug discovery companies to tackle some of the biggest problems facing the industry. These include patient access to cell and gene therapies, the development of DNA gene therapies, and the challenges surrounding GI clinical trials.  Delbert acquires injectable antibiotic from Bristol… Read More

#Business & Investment #News

#2025 predictions #Cell and gene therapy #Drug discovery

Cell and gene therapy: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience and cancer research. Here, looking at cell and gene therapy. For the last few… Read More

#Business & Investment #Exclusive Content #Trends & Analysis

#Absci #AI / data analytics / healthtech / informatics #Antibodies #Artificial intelligence (AI) #Drug discovery #Drug targets #Interview #Machine learning

New podcast: The continued evidence of AI’s drug discovery value

This is the latest episode of the free DDW narrated podcast, titled “The continued evidence of AI’s drug discovery value”, which covers two articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: “How generative AI could improve drug discovery” and “Can… Read More

#News

#2025 predictions #Cancer #Cancer research #Drug discovery

Cancer burden and research: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience. Here, looking at cancer burden and research in the sector. Ahead of World Cancer Day… Read More

#Business & Investment #Cancer Research #Exclusive Content #Trends & Analysis

Lab Automation
#Automated liquid handling #Automation / robotics #Drug discovery #Lab automation #Lab equipment #Lab of the future #Survey

Report reveals scale of opportunity for automation suppliers

The vast majority (80%) of researchers are using automation in less than half of their laboratory processes, despite the hype around these technologies. This is one of the key findings of the DDW Research & Consultancy 2025 Research Report Purchasing in Drug Discovery Lab Automation:… Read More

#Editor's Choice #News

World Health Organization
#Big pharma #Drug development #Opinion #Politics #World Health Organization

How will a Trump withdrawal from the WHO impact drug development?

In one of his first acts as President, Donald Trump signed an executive order to withdraw the US from the World Health Organization (WHO). DDW’s Megan Thomas spoke with three industry leaders to understand the impact this will have on the drug development sector. Cell and gene therapy According… Read More

#Business & Investment #Exclusive Content #Opinion #Regulatory

#2025 predictions #Drug discovery #Neuroscience

Neuroscience: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, this was with a focus on technology, machine learning (ML) and artificial intelligence (AI). Here, looking at the neuroscience sector. At the Society for Neuroscience’s annual meeting, Neuroscience 2024, both the… Read More

#Business & Investment #Exclusive Content #Trends & Analysis

#Digital therapeutics #Drug development #FDA #Regulatory

Streamlining the development of digital therapeutics

Acacia Parks, PhD, MBA, Advisor to Lindus Health, discusses the journey to commercialisation for digital therapeutics and how best to engage the FDA in this process.  While there is no “one size fits all” approach to the development of any class of treatments, this is especially true for digital… Read More

#Exclusive Content

San Diego Conference Centre
#Automation / robotics #Events #Lab equipment #SLAS2025

SLAS2025 Day 3

The Society for Laboratory Automation and Screening (SLAS) international conference (SLAS2025) concluded on Wednesday 29 January. Award winners Congratulations to the 2025 SLAS Ignite Award winner, InSimili. The Ignite Award is given to the most promising Innovation AveNEW for Startups participant and is scored on marketing… Read More

#News

San Diego Conference Centre
#Automation / robotics #Events #Lab equipment #SLAS2025

SLAS2025 Day 2

The Society for Laboratory Automation and Screening (SLAS) international conference (SLAS2025) continued on Tuesday 28 January. Members of the DDW team meeting Tom Cruise on the Midway. Monday Night Party The annual Hamilton Monday Night Party was held aboard the USS Midway and was very well-attended. Award… Read More

#News

#Artificial intelligence (AI) #Drug discovery

Webinar: The benefits of generative AI in drug discovery – Amazon Web Services (AWS) – 28.01.2025

It can take years, and cost billions, to get new drugs approved for clinical use, but technological advances are transforming drug discovery and development. The growing shift towards artificial intelligence (AI), including generative and predictive AI, can reduce the amount of time and money it takes to develop new… Read More

#Webinars

#Drug discovery

Webinar: Safeguarding Genetic Integrity in Preclinical Rodent Models

Join geneticist Bart Smits, PhD in this exclusive webinar as he outlines key considerations for designing and maintaining a robust mouse colony to support your preclinical research needs. Secure your spot to: Understand the impact of background strain and substrain on mutation expression. Explore effective… Read More

#Webinars

San Diego Conference Centre
#Automation / robotics #Events #Lab equipment #SLAS2025

SLAS2025 Day 1

The Society for Laboratory Automation and Screening (SLAS) international conference (SLAS2025) kicked off in San Diego on Monday 27 January. Keynote session SLAS CEO and President Vicki Loise welcomed SLAS2025 attendees to the opening keynote session, sponsored by Thermo Fisher Scientific. After acknowledging and thanking those… Read More

#News

#AI / data analytics / healthtech / informatics #Amazon Web Services (AWS) #Artificial intelligence (AI) #Drug development #Drug discovery #Generative AI

Last chance to register: Generative AI in drug discovery

In this webinar, discover how high-performance computing (HPC) and AI are being used to screen out potentially dangerous drugs, improve the identification of drug candidates, and develop new therapeutic compounds. It can take years, and cost billions, to get new drugs approved for clinical use, but technological… Read More

Webinar date:
Supported by Amazon Web Services and NVIDIA
#News